Ultragenyx Pharmaceutical, Inc. (RARE) CEO Emil Kakkis on Q1 2022 Results - Earnings Call Transcript
Ultragenyx Pharmaceutical, Inc. (NASDAQ:NASDAQ:RARE) Q1 2022 Earnings Conference Call May 05, 2022, 17:00 ET Company Participants Joshua Higa - Director, IR & Corporate Communications...
Source: seekingalpha.com